A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up

Published 2015 View Full Article

Authors

Keywords

Multiple sclerosis, Human endogenous retrovirus, Monoclonal antibody, Clinical trial, Safety

Journal

JOURNAL OF NEUROIMMUNOLOGY

Volume 285, Issue -, Pages 68-70

Publisher

Elsevier BV

Online

2015-05-21

DOI

10.1016/j.jneuroim.2015.05.019

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started